Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II study of OB756 tablets in myelofibrosis and related myeloproliferative neoplasms
CTR20201950Phase 2Active
- Sponsor
- Huadong Medicine
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bewintinib in primary myelofibrosis (PMF), myelofibrosis (MF), polycythemia vera (PV), thrombocythemia, sponsored by Huadong Medicine. Started Nov 2020; status: active.
02
Drugs
bewintinib
03
Conditions
primary myelofibrosis (PMF)myelofibrosis (MF)polycythemia vera (PV)thrombocythemia
Beyond the preview
Go deeper on CTR20201950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201950.